Braidwell »

CVS Caremark Corporation shares owned by Braidwell

Quarter-by-quarter ownership of CVS Caremark Corporation (CVS) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in CVS Caremark Corporation

Tip: Access up to 7 years of quarterly data

All positions including CVS Caremark Corporation held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CVS Caremark Corporation by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 439k 75.39

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding CVS Caremark Corporation

BlackRock
Vanguard Group
Dodge & Cox
Capital World Investors
State Street Corporation
FMR
Jpmorgan Chase & Co
Geode Capital Management
Capital Research and Management Company - Division 3
Invesco
Morgan Stanley
Pzena Investment Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding CVS Caremark Corporation